# Pilot Study of Vitamin K2 (MK-7) and Vitamin D3 Supplementation and the Effects on PASC Symptomatology and Inflammatory Biomarkers

> **NCT05356936** · NA · COMPLETED · sponsor: **University Hospitals Cleveland Medical Center** · enrollment: 151 (actual)

## Conditions studied

- Post-acute COVID-19 Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** Vitamin K2 (MK-7)
- **DIETARY_SUPPLEMENT:** Vitamin D3

## Key facts

- **NCT ID:** NCT05356936
- **Lead sponsor:** University Hospitals Cleveland Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-01
- **Primary completion:** 2024-04-01
- **Final completion:** 2024-08-01
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2024-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05356936

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05356936, "Pilot Study of Vitamin K2 (MK-7) and Vitamin D3 Supplementation and the Effects on PASC Symptomatology and Inflammatory Biomarkers". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05356936. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*